Moneycontrol PRO
HomeNewsBusinessCoronavirus testing | IIT Delhi’s Corosure kit prices could drop 20-30% once bulk production begins

Coronavirus testing | IIT Delhi’s Corosure kit prices could drop 20-30% once bulk production begins

The Corosure kit, currently priced at Rs 399, is the cheapest one yet in the market, and is approved by the Drug Control General of India and the Indian Medical Council

July 23, 2020 / 14:09 IST
Representative image

Indian Institute of Technology (IIT) Delhi’s Corosure kit for coronavirus testing has been launched in the commercial market for Rs 399. It is the cheapest testing kit yet in the market and is approved by the Drug Control General of India (DCGI) and the Indian Medical Council (IMC).

However, it will not be available over-the-counter: “It can be done only in a certified lab performing RT-PCR tests for COVID-19,” V Perumal, Lead Researcher from IIT Delhi behind the development of the diagnostic assay told Moneycontrol via email.

Perumal said the price could reduce by as much as 20-30 percent from the current base price of Rs 399 once bulk manufacturing picks up

“IIT-Delhi has so far transferred the technology to 10 companies, including NewTech Medical Devices. We expect two to three more licensees to obtain the Central Drugs Standard Control Organisation (CSDCO) manufacturing license in the next 10 days,” Perumal said.

When asked about a timeline for mass production of the product, Perumal said this would be as per the companies’ timelines and NewTech has already outlined its goals. NewTech Medical Devices is among the first to commercially develop the product under license from IIT-Delhi. The company is looking to produce two million units by August 2020, as per reports.

COVID-19 Vaccine

Frequently Asked Questions

View more
How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

View more
Show

Follow our LIVE Updates on the coronavirus pandemic here

“Our licensees are spread across 5 states. The test should be available in all Indian states,” he said.

Meanwhile speaking at a virtual launch event, HRD Minister Ramesh Pokhriyal said the indigenously developed kit can help control the pandemic as it offers a reliable and affordable testing option. It will be made available for authorised testing labs and another 10 companies besides NewTech have been issued licenses by IIT Delhi to mass-produce the device, he added.

Researchers at IIT Delhi are also working with the National Chemical Laboratory (NCL) in Pune to develop another testing kit suitable for home use and quick results, institute’s director V Ramgopal Rao told the paper.

Follow our full COVID-19 coverage here

Jocelyn Fernandes
first published: Jul 23, 2020 02:08 pm

Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

Subscribe to Tech Newsletters

  • On Saturdays

    Find the best of Al News in one place, specially curated for you every weekend.

  • Daily-Weekdays

    Stay on top of the latest tech trends and biggest startup news.

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347